Zilbrysq multiple strengths Images
Generic Name: zilucoplan
This medication has been identified as Zilbrysq multiple strengths. It is supplied by UCB, Inc.
Zilbrysq is used in the treatment of Myasthenia Gravis and belongs to the drug class selective immunosuppressants. Zilbrysq multiple strengths is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zilbrysq
- Generic Name
- zilucoplan
- Strength
- multiple strengths
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- UCB, Inc.
- National Drug Code (NDC)
- multiple
See also:
Rystiggo
Rystiggo is used to treat generalized myasthenia gravis (gMG) in adults who are acetylcholine ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Vyvgart
Vyvgart is used for myasthenia gravis to improve muscle weakness in adults whose myasthenia gravis ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Vyvgart Hytrulo
Vyvgart Hytrulo is used to treat generalized myasthenia gravis (gMG) or chronic inflammatory ...
Eculizumab
Eculizumab (brand names Soliris, Bkemv, and Epysqli) is used to treat paroxysmal nocturnal ...
Neostigmine
Neostigmine is used for myasthenia gravis, reversal of neuromuscular blockade, reversal of ...
Pyridostigmine
Pyridostigmine is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
More about Zilbrysq (zilucoplan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.